Table of Contents

1 Industry Overview

• 1.1 Pulmonary Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Pulmonary Drugs
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Pulmonary Drugs Market by Type

• 3.1 By Type
  • 3.1.1 Inhaled Corticosteroids (ICS)
  • 3.1.2 Long-Acting Beta2-Agonists (LABA)
  • 3.1.3 Antihistamine
  • 3.1.4 Vasodilators
  • 3.1.5 Short-Acting Beta2-Agonists (SABA)
  • 3.1.6 Anticholinergics
  • 3.1.7 Combination Drugs
  • 3.1.8 MAbs
  • 3.1.9 Enzymes
  • 3.1.10 Antibiotics & Antileukotrienes
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Pulmonary Drugs AstraZeneca plc (Company Profile, Sales Data etc.)

• 4.2 Bayer AG (Company Profile, Sales Data etc.)
• 4.3 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
• 4.4 Actelion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
• 4.5 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
• 4.6 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
• 4.7 Merck & Co., Inc. (Company Profile, Sales Data etc.)
• 4.8 Novartis AG (Company Profile, Sales Data etc.)
• 4.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
• 4.10 Sunovion Pharmaceuticals (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Asthma & COPD
  • 6.1.2 Demand in Allergic Rhinitis
  • 6.1.3 Demand in Pulmonary Arterial Hypertension
  • 6.1.4 Demand in Cystic Fibrosis
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Pulmonary Drugs

Table Application Segment of Pulmonary Drugs

Table Global Pulmonary Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Inhaled Corticosteroids (ICS)

Table Major Company List of Long-Acting Beta2-Agonists (LABA)

Table Major Company List of Antihistamine

Table Major Company List of Vasodilators

Table Major Company List of Short-Acting Beta2-Agonists (SABA)

Table Major Company List of Anticholinergics

Table Major Company List of Combination Drugs

Table Major Company List of MAbs

Table Major Company List of Enzymes

Table Major Company List of Antibiotics & Antileukotrienes

Table Global Pulmonary Drugs Market 2013-2018, by Type, in USD Million

Table Global Pulmonary Drugs Market 2013-2018, by Type, in Volume

Table Global Pulmonary Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Pulmonary Drugs Market Forecast 2019-2024, by Type, in Volume

Table AstraZeneca plc Overview List

Table Pulmonary Drugs Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Pulmonary Drugs Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Ltd Overview List

Table Pulmonary Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Actelion Pharmaceuticals, Inc. Overview List

Table Pulmonary Drugs Business Operation of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim GmbH Overview List

Table Pulmonary Drugs Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Pulmonary Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co., Inc. Overview List

Table Pulmonary Drugs Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis AG Overview List

Table Pulmonary Drugs Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline plc Overview List

Table Pulmonary Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sunovion Pharmaceuticals Overview List

Table Pulmonary Drugs Business Operation of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Pulmonary Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Pulmonary Drugs Sales Revenue Share, by Company, in USD Million

Table Global Pulmonary Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Pulmonary Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Pulmonary Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Pulmonary Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Pulmonary Drugs Production 2013-2018, by Region, in USD Million

Table Pulmonary Drugs Production 2013-2018, by Region, in Volume

Table Global Pulmonary Drugs Market 2013-2018, by Region, in USD Million

Table Global Pulmonary Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Pulmonary Drugs Market 2013-2018, by Region, in Volume

Table Global Pulmonary Drugs Market Share 2013-2018, by Region, in Volume

Table North America Pulmonary Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Pulmonary Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Pulmonary Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Pulmonary Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Pulmonary Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Pulmonary Drugs Market Size 2013-2018, by Country, in Volume

Table South America Pulmonary Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Pulmonary Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Pulmonary Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Pulmonary Drugs Market Size 2013-2018, by Country, in Volume

Table Pulmonary Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Pulmonary Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Pulmonary Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Pulmonary Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Pulmonary Drugs Market Concentration, in 2018

Figure Europe Pulmonary Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Pulmonary Drugs MMarket Concentration, in 2018

Figure South America Pulmonary Drugs Market Concentration, in 2018

Figure Middle East & Africa Pulmonary Drugs Market Concentration, in 2018

Figure Pulmonary Drugs Demand in Asthma & COPD, 2013-2018, in USD Million

Figure Pulmonary Drugs Demand in Asthma & COPD, 2013-2018, in Volume

Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2013-2018, in USD Million

Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2013-2018, in Volume

Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2013-2018, in USD Million

Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2013-2018, in Volume

Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2013-2018, in USD Million

Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2013-2018, in Volume

Figure North America Pulmonary Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Pulmonary Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Pulmonary Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Pulmonary Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Pulmonary Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Pulmonary Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Pulmonary Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)